The presence of naturally occurring anti-MUC1 antibodies specific for the unglycosylated peptide backbone epitopes has been correlated with better disease prognosis and serves as a well-established biomarker for multiple cancer types [10,11]. This evidence concerns the gene MUC1 and cancer.